These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24956242)

  • 1. New strategies could lead to more personalized therapies for cancer.
    Jones S
    Pharmacogenomics; 2014 May; 15(7):901-2. PubMed ID: 24956242
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. Personalized cancer diagnostics.
    Corless CL
    Science; 2011 Dec; 334(6060):1217-8. PubMed ID: 22144608
    [No Abstract]   [Full Text] [Related]  

  • 3. [Personalized therapeutic targeting by exome analysis].
    Lamy A; Angot E; Sabourin JC
    Ann Pathol; 2012 Nov; 32(5 Suppl):S44-5. PubMed ID: 23127937
    [No Abstract]   [Full Text] [Related]  

  • 4. From cancer genomics to precision oncology--tissue's still an issue.
    Cohen RL; Settleman J
    Cell; 2014 Jun; 157(7):1509-14. PubMed ID: 24949964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology as the driving force for personalized oncology.
    Oktay MH; Hui P
    Expert Rev Mol Diagn; 2012 Nov; 12(8):811-3. PubMed ID: 23249199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine benefits patients in early trials: matching targeted therapies with gene mutations is associated with better outcomes, even in phase 1 studies.
    Printz C
    Cancer; 2012 Oct; 118(20):4911-2. PubMed ID: 23042614
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized oncology: genomic screening in phase 1.
    Tuxen IV; Jønson L; Santoni-Rugiu E; Hasselby JP; Nielsen FC; Lassen U
    APMIS; 2014 Aug; 122(8):723-33. PubMed ID: 25046202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the future for cancer clinical trials?
    Perrone F
    Future Oncol; 2015; 11(1):5-7. PubMed ID: 25572779
    [No Abstract]   [Full Text] [Related]  

  • 9. Epigenetic profiling joins personalized cancer medicine.
    Heyn H; Méndez-González J; Esteller M
    Expert Rev Mol Diagn; 2013 Jun; 13(5):473-9. PubMed ID: 23782254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
    Arnedos M; Vielh P; Soria JC; Andre F
    J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging personalized oncology: sequencing and systems strategies.
    Cho W; Ziogas DE; Katsios C; Roukos DH
    Future Oncol; 2012 Jun; 8(6):637-41. PubMed ID: 22764759
    [No Abstract]   [Full Text] [Related]  

  • 12. Personalized medicine in oncology: where have we come from and where are we going?
    André F; Ciccolini J; Spano JP; Penault-Llorca F; Mounier N; Freyer G; Blay JY; Milano G
    Pharmacogenomics; 2013 Jun; 14(8):931-9. PubMed ID: 23746187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
    Scolyer RA; Thompson JF
    J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
    [No Abstract]   [Full Text] [Related]  

  • 15. Personalized medicine: through the looking glass of functional imaging.
    Hohl RJ
    Clin Cancer Res; 2013 Aug; 19(15):4024-6. PubMed ID: 23785049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fast track to personalized medicine?: whole-genome sequencing may lead to better cancer therapies.
    Nelson B
    Cancer Cytopathol; 2012 Oct; 120(5):283-4. PubMed ID: 23065928
    [No Abstract]   [Full Text] [Related]  

  • 18. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor heterogeneity as the foundation of personalized cancer treatment.
    Schilsky RL
    Semin Oncol; 2011 Apr; 38(2):171-2. PubMed ID: 21421107
    [No Abstract]   [Full Text] [Related]  

  • 20. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.